156 related articles for article (PubMed ID: 34029877)
1. Diagnostic value of syndecan-4 protein expression in colorectal cancer.
Jechorek D; Haeusler-Pliske I; Meyer F; Roessner A
Pathol Res Pract; 2021 Jun; 222():153431. PubMed ID: 34029877
[TBL] [Abstract][Full Text] [Related]
2. Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: an immunohistochemical study of clinically annotated tumors.
Hashimoto Y; Skacel M; Adams JC
BMC Cancer; 2008 Jun; 8():185. PubMed ID: 18590537
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
4. High expression of CASK correlates with progression and poor prognosis of colorectal cancer.
Wei JL; Fu ZX; Fang M; Zhou QY; Zhao QN; Guo JB; Lu WD; Wang H
Tumour Biol; 2014 Sep; 35(9):9185-94. PubMed ID: 24927672
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-2 is upregulated in colorectal cancer cells through interactions with extracellular matrix produced by stromal fibroblasts.
Vicente CM; Ricci R; Nader HB; Toma L
BMC Cell Biol; 2013 May; 14():25. PubMed ID: 23705906
[TBL] [Abstract][Full Text] [Related]
6. Effects of syndecan-4 gene silencing by micro RNA interference in anoikis resistant endothelial cells: Syndecan-4 silencing and anoikis resistance.
Onyeisi JOS; Pernambuco Filho PCA; Mesquita APS; Azevedo LC; Nader HB; Lopes CC
Int J Biochem Cell Biol; 2020 Nov; 128():105848. PubMed ID: 32927086
[TBL] [Abstract][Full Text] [Related]
7. Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival.
Poças J; Marques C; Gomes C; Otake AH; Pinto F; Ferreira M; Silva T; Faria-Ramos I; Matos R; Ribeiro AR; Senra E; Cavadas B; Batista S; Maia J; Macedo JA; Lima L; Afonso LP; Ferreira JA; Santos LL; Polónia A; Osório H; Belting M; Reis CA; Costa-Silva B; Magalhães A
Proc Natl Acad Sci U S A; 2023 May; 120(20):e2214853120. PubMed ID: 37155874
[TBL] [Abstract][Full Text] [Related]
8. Effects of syndecan-4 silencing on the extracellular matrix remodeling in anoikis-resistant endothelial cells.
Onyeisi JOS; Nader HB; Lopes CC
Cell Biol Int; 2024 Jun; 48(6):883-897. PubMed ID: 38591778
[TBL] [Abstract][Full Text] [Related]
9. Heparan Sulfate Proteoglycans in Human Colorectal Cancer.
Vicente CM; da Silva DA; Sartorio PV; Silva TD; Saad SS; Nader HB; Forones NM; Toma L
Anal Cell Pathol (Amst); 2018; 2018():8389595. PubMed ID: 30027065
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-4 in Tumor Cell Motility.
Keller-Pinter A; Gyulai-Nagy S; Becsky D; Dux L; Rovo L
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282767
[TBL] [Abstract][Full Text] [Related]
11. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
12. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
[TBL] [Abstract][Full Text] [Related]
13. Expression and Function of a Disintegrin and Metalloproteinases in Cancer-Associated Fibroblasts of Colorectal Cancer.
Mochizuki S; Ao T; Sugiura T; Yonemura K; Shiraishi T; Kajiwara Y; Okamoto K; Shinto E; Okada Y; Ueno H
Digestion; 2020; 101(1):18-24. PubMed ID: 31722362
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-4 Modulates Epithelial Gut Barrier Function and Epithelial Regeneration in Experimental Colitis.
Fröhling M; Tepasse P; Intemann J; Sambale M; Sherwood J; Paruzel P; Tiemeyer NM; Nowacki TM; Brückner M; Mennigen R; Lügering A; Echtermeyer F; Pap T; Stratis A; Bettenworth D
Inflamm Bowel Dis; 2018 Nov; 24(12):2579-2589. PubMed ID: 30053064
[TBL] [Abstract][Full Text] [Related]
15. Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma.
Wang XQ; Tang ZX; Yu D; Cui SJ; Jiang YH; Zhang Q; Wang J; Yang PY; Liu F
Oncotarget; 2016 Feb; 7(8):8823-38. PubMed ID: 26741506
[TBL] [Abstract][Full Text] [Related]
16. High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma.
Zhu Y; Zheng D; Lei L; Cai K; Xie H; Zheng J; Yu C
BMC Cancer; 2022 Oct; 22(1):1042. PubMed ID: 36199068
[TBL] [Abstract][Full Text] [Related]
17. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-4 and fibronectin in osteosarcoma.
Na KY; Bacchini P; Bertoni F; Kim YW; Park YK
Pathology; 2012 Jun; 44(4):325-30. PubMed ID: 22531343
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma.
Erdem M; Erdem S; Sanli O; Sak H; Kilicaslan I; Sahin F; Telci D
Urol Oncol; 2014 Jan; 32(1):25.e13-20. PubMed ID: 23499501
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
